Stay updated with breaking news from Kjell Andersson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs,...
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs
Gothenburg, Sweden,9 November 2022 – Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs, is pleased to announce the confirmation of Christer Nordstedt MD.PhD. as Chief Executive Officer (CEO). Christer Nordstedt will assume the position on 1st December 2022.
60% of Europe’s renewable energy comes from biomass. That’s largely the burning of wood to create electricity. FM4’s Klimanews Weekly asks whether this is really green energy?